Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.02
-1.76 (-6.83%)
Jan 30, 2026, 4:00 PM EST - Market closed
Pelthos Therapeutics Employees
As of December 31, 2024, Pelthos Therapeutics had 11 total employees, including 4 full-time and 7 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
$673,273
Profits / Employee
-$2,143,758
Market Cap
74.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 11 | 3 | 37.50% | 4 | 7 |
| Dec 31, 2023 | 8 | 6 | 300.00% | 4 | 4 |
| Sep 30, 2023 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2022 | 3 | 1 | 50.00% | 3 | 0 |
| Jun 30, 2022 | 3 | - | - | 3 | 0 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pliant Therapeutics | 171 |
| XBiotech | 88 |
| aTyr Pharma | 65 |
| PolyPid | 60 |
| ALX Oncology Holdings | 44 |
| Gain Therapeutics | 25 |
| Atossa Therapeutics | 15 |
| Annovis Bio | 15 |
PTHS News
- 15 days ago - Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics - Business Wire
- 18 days ago - Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance - GlobeNewsWire
- 26 days ago - Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice - GlobeNewsWire
- 2 months ago - Pelthos Pharmaceuticals: Off To A Strong Start With Zelsuvmi, Continued Sales Growth Is Likely - Seeking Alpha
- 2 months ago - Pelthos Therapeutics Inc. (PTHS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 3 months ago - Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing - GlobeNewsWire
- 3 months ago - Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025 - GlobeNewsWire